Drivers of cost differences between US breast cancer survivors with or without lymphedema

ConclusionsElevated patient costs for BCS with lymphedema are for more than lymphedema itself, suggesting that financial coverage for lymphedema treatment alone may not eliminate cost disparities.Implications for Cancer SurvivorsThe economic challenges examined in this paper have long been a concern of BCS and advocates, with only recent attention by policy makers, researchers, and providers. BCS identified potential policy and programmatic solutions, including expanding insurance coverage and financial assistance for BCS across socioeconomic levels.

Source: Journal of Cancer Survivorship - August 23, 2019 Category: Cancer & Oncology Source Type: research